« Back
Home /
Gentamicin (sulfate)

Gentamicin (sulfate)

Item no.	HY-A0276-10mM
Manufacturer	MedChem Express
CASRN	1405-41-0
Amount	10 mMx1 mL
Quantity options	10 mMx1 mL 1 g 500 mg 5 g
Category	Food Safety Antibiotics Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Citations	[1]Xu W, et al. A rapid and sensitive method for kinetic study and activity assay of DNase I in vitro based on a GO-quenched hairpin probe. Anal Bioanal Chem. 2016 May;408(14):3801-9.\|[2]Rudin A, et al. Antibacterial activity of gentamicin sulfate in tissue culture. Appl Microbiol. 1970 Dec;20(6):989-90.\|[3]Kumar CG, et al. Microbial biosynthesis and applications of gentamicin: a critical appraisal.\|[4]Espersen F, et al. Effect of treatment with methicillin and gentamicin in a new experimental mouse model of foreignbody infection. Antimicrob Agents Chemother. 1994 Sep;38(9):2047-53. ACS Appl Mater Interfaces. 2019 Oct 16;11(41):38190-38204. ACS Infect Dis. 2024 Apr 12;10(4):1327-1338. Am J Physiol Cell Physiol. 2019 Aug 1;317(2):C277-C286. Appl Microbiol Biotechnol. 2022 Apr;106(7):2689-2702. Aquaculture. 2021, 736248. Autophagy. 2025 Jul 27:1-23. Cancer Cell. 2025 Jul 29:S1535-6108(25)00318-6. Cell Death Dis. 2023 Jan 11;14(1):15. Cell Host Microbe. 2024 Jul 23:S1931-3128(24)00254-3. Cell Transplant. 2021 Jan-Dec:30:963689721997151. Evid Based Complement Alternat Med. 2015:2015:639412. Immun Inflamm Dis. 2024 Jul;12(7):e1149. Int J Biol Sci. 2024 Oct 7;20(14):5415-5435. J Ethnopharmacol. 2020 Sep 15;259:112882. Mol Immunol. 2017 Dec:92:151-160. Mol Med Rep. 2016 Dec;14(6):5304-5310. Mutat Res Genet Toxicol Environ Mutagen. 2023 May-Jun:888:503636. Nat Aging. 2025 May;5(5):848-867. Nat Commun. 2022 Mar 2;13(1):1116. Research Square Print. October 6th, 2022. Toxicology. 2023 Jan 1:483:153386. AMB Express. 2024 Dec 24;14(1):141. Bio Protoc. 2025 Feb 20;15(4):e5221. Biochem Pharmacol. 2025 Sep 17;242:117343. Biomed Pharmacother. 2023 Dec 31:169:115856. bioRxiv. 2024 May 10. BMC Microbiol. 2025 Apr 29;25(1):257. Cancer Res. 2025 Oct 9. Cell. 2024 Feb 15;187(4):882-896.e17 Chin J Traumatol. 2024 Jul 3:S1008-1275(24)00075-0. Curr Microbiol. 2023 May 31;80(7):230. Curr Microbiol. 2025 Aug 16;82(10):456. Curr Res Food Sci. 2025 May 16:10:101084. Cytotherapy. 2025 Sep 13. Emerg Microbes Infect. 2024 Dec;13(1):2321981. Exp Eye Res. 2025 Oct 16:262:110698. Food Chem. 2023 Mar 1:403:134399. Food Funct. 2025 Feb 3;16(3):1041-1059. Future Microbiol. 2025 Oct 13:1-10. Infect Genet Evol. 2025 Sep:133:105780. Int Immunopharmacol. 2025 May 21:159:114888. Int J Biol Macromol. 2025 May;305(Pt 2):141278. Int J Infect Dis. 2026 Jan:162:108165. Int J Med Microbiol. 2023 Mar 28;313(2):151578. MedComm (2020). 2025 Jan 8;6(1):e70046. Microbiol Spectr. 2025 Aug 29:e0059025. Microbiol Spectr. 2025 May 19:e0307424. Microbiol Spectr. 2025 Oct 16:e0160325. Microorganisms. 2024 Mar 13;12(3):575. Microorganisms. 2025 Apr 18;13(4):938. Nat Microbiol. 2023 Mar;8(3):410-423. Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr;398(4):3681-3695. Patent. US20240319170A1 Pathogens. 2024 Nov 15;13(11):1003. Physiol Res. 2025 Mar 24;74(1):79-92. Transl Lung Cancer Res. 2025 Jun 30;14(6):2159-2179. Vet Microbiol. 2024 May:292:110046. Vet Res Commun. 2024 Dec;48(6):3859-3872. Virulence. 2024 Dec;15(1):2415952. World J Gastroenterol. 2025 Jul 28;31(28):107361.
Smiles	O=S(O)(O)=O.O[C@]1(C)C(NC)[C@@H](O)[C@@H](O[C@H]2C(N)C[C@H](N)[C@@H](O[C@@H]3[C@H](N)CC[C@@H]([R])O3)[C@@H]2O)OC1.NC[].C[C@H]([])N.C[C@H]([*])NC.[R=].[or].[or]
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Shipping Condition	Room temperature
Available
Manufacturer - Type	Natural Products
Manufacturer - Applications	COVID-19-anti-virus
Manufacturer - Category	Reference compound / Active compounds; API; Natural Products
Manufacturer - Targets	Antibiotic; Bacterial
Manufacturer - HS Code	H317
Shipping Temperature	Room Temperature
Storage Conditions	4°C (Powder, sealed storage, away from moisture)
Molecular Weight	561.65 (Average)
Product Description	Gentamicin sulfate, an orally active aminoglycoside antibiotic, inhibits the growth of both gram-positive and gram-negative bacteria and to inhibit several strains of mycoplasma in tissue culture. Gentamicin sulfate inhibits DNase I with an IC50 of 0.57 mM[1][2][3][4].
Manufacturer - Research Area	Infection; Cancer
Solubility	DMSO : < 1 mg/mL (ultrasonic; warming; heat to 60°C)\|H2O : 100 mg/mL (ultrasonic)
Manufacturer - Pathway	Anti-infection
Clinical information	Launched
Isoform	Aminoglycoside
UNSPSC Code	12352211
Precautionary	H317

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.